ARIPIPRAZOLE TEVA 15 mg, tablet 28 tablets, CIP 3400930017401
Active ingredients: Aripiprazole
Commercialized according to BDPMDispensing in France: Prescription only
Tablet28 tablets, CIP 3400930017401orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ARIPIPRAZOLE TEVA 15 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium de 28 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 28 Feb 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64807679CIP73001740CIP133400930017401Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ARIPIPRAZOLEcomprimé | 15 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.